SARMISTHA KUMAR
Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation VISTA, CA NPI 1720002058
Browse related groups: Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation CA ORGANOGENESIS INC. All categories
General Payments — all program years on this page
$737.78
- Category: General Payments
- Program years: PY2018–2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $170.16 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $170.16 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ORGANOGENESIS INC. | $32.67 | 2 |
| Aurinia Pharma U.S., Inc. | $28.46 | 1 |
| Lilly USA, LLC | $28.21 | 1 |
| Janssen Biotech, Inc. | $24.10 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.68 | 1 |
| Astellas Pharma US Inc | $17.85 | 1 |
| GENZYME CORPORATION | $17.19 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078353388 | Janssen Biotech, Inc. | $24.10 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135378576 | Lilly USA, LLC | $28.21 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139164060 | RECORDATI_RARE_DISEASES_INC. | $21.68 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139409087 | Astellas Pharma US Inc | $17.85 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139689976 | GENZYME CORPORATION | $17.19 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145434980 | Organogenesis Inc. | $17.46 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145434982 | Organogenesis Inc. | $15.21 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150685347 | Aurinia Pharma U.S., Inc. | $28.46 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.